Lindbrook Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Lindbrook Capital, LLC

  • $1.05 Billion
  • Q1 2024

A detailed history of Lindbrook Capital, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 1,119 shares of REGN stock, worth $1.18 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,119
Previous 1,104 1.36%
Holding current value
$1.18 Million
Previous $969,000 11.15%
% of portfolio
0.1%
Previous 0.1%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024
BUY
$902.69 - $993.35 $13,540 - $14,900
15 Added 1.36%
1,119 $1.08 Million
Q4 2023

Jan 31, 2024
BUY
$775.18 - $881.7 $57,363 - $65,245
74 Added 7.18%
1,104 $969,000
Q3 2023

Oct 25, 2023
BUY
$692.45 - $844.37 $25,620 - $31,241
37 Added 3.73%
1,030 $847,000
Q2 2023

Jul 28, 2023
SELL
$700.03 - $830.35 $33,601 - $39,856
-48 Reduced 4.61%
993 $713,000
Q1 2023

Apr 26, 2023
BUY
$680.49 - $826.97 $53,758 - $65,330
79 Added 8.21%
1,041 $855,000
Q4 2022

Jan 24, 2023
BUY
$705.89 - $766.39 $24,000 - $26,057
34 Added 3.66%
962 $0
Q3 2022

Nov 10, 2022
BUY
$573.97 - $724.32 $19,514 - $24,626
34 Added 3.8%
928 $639,000
Q2 2022

Aug 01, 2022
SELL
$548.35 - $738.84 $9,321 - $12,560
-17 Reduced 1.87%
894 $528,000
Q1 2022

Apr 21, 2022
BUY
$595.12 - $698.43 $7,736 - $9,079
13 Added 1.45%
911 $636,000
Q4 2021

Jan 18, 2022
SELL
$543.48 - $670.97 $543 - $670
-1 Reduced 0.11%
898 $567,000
Q3 2021

Nov 05, 2021
BUY
$574.03 - $680.96 $4,592 - $5,447
8 Added 0.9%
899 $544,000
Q2 2021

Jul 27, 2021
BUY
$472.8 - $558.54 $24,112 - $28,485
51 Added 6.07%
891 $498,000
Q1 2021

Apr 28, 2021
SELL
$446.73 - $548.2 $17,422 - $21,379
-39 Reduced 4.44%
840 $397,000
Q4 2020

Jan 27, 2021
BUY
$478.3 - $607.98 $24,393 - $31,006
51 Added 6.16%
879 $425,000
Q3 2020

Nov 03, 2020
SELL
$544.75 - $658.21 $24,513 - $29,619
-45 Reduced 5.15%
828 $463,000
Q2 2020

Jul 27, 2020
BUY
$493.32 - $643.92 $5,426 - $7,083
11 Added 1.28%
873 $544,000
Q1 2020

Apr 22, 2020
SELL
$336.18 - $494.43 $1,008 - $1,483
-3 Reduced 0.35%
862 $421,000
Q4 2019

Jan 27, 2020
BUY
$274.13 - $376.51 $1,370 - $1,882
5 Added 0.58%
865 $325,000
Q3 2019

Oct 31, 2019
BUY
$273.46 - $318.39 $18,595 - $21,650
68 Added 8.59%
860 $239,000
Q2 2019

Jul 24, 2019
SELL
$299.6 - $414.82 $14,380 - $19,911
-48 Reduced 5.71%
792 $247,000
Q4 2018

Feb 07, 2019
BUY
$335.82 - $403.04 $282,088 - $338,553
840 New
840 $313,000

Others Institutions Holding REGN

# of Institutions
1,424
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $113B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email